Maccura Biotechnology Co.Ltd Stock Value
Maccura Biotechnology Co.Ltd Company Info
EPS Growth 5Y
-26,21%
Market Cap
¥6,58 B
Long-Term Debt
¥0,18 B
Quarterly earnings
04/24/2026
Dividend
¥0,10
Dividend Yield
0,96%
Founded
1994
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
There are currently no price targets available for this stock.
In the last five quarters, Maccura Biotechnology Co.Ltd’s Price Target has risen from ¥19,40 to ¥19,40 - a 0,00% increase. Two analysts predict that Maccura Biotechnology Co.Ltd’s share price will fall in the coming year, reaching ¥0,00. This would represent a decrease of -100,00%.
Top growth stocks in the health care sector (5Y.)
What does Maccura Biotechnology Co.Ltd do?
Maccura Biotechnology Co.Ltd engages in the development, production, and sales of in vitro diagnostic products.
Business Segments
The company operates through several business segments, each focusing on different aspects of in vitro diagnostics. Its primary segment is the production and sales of diagnostic reagents, which include a wide range of products for various medical tests and analyses. The company’s diagnostic instruments segment provides advanced equipment for laboratories, enhancing...
Maccura Biotechnology Co.Ltd Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Revenue by Segment:**
- Diagnostic devices: approx. 60%
- Reagents and consumables: approx. 30%
- Services and others: approx. 10%
**TOP 3 Markets and their Percentage Shares:**
- China: approx. 70%
- USA: approx. 15%
- Europe: approx. 10%
Maccura Biotechnology Co. Ltd is mainly active in the fi...
At which locations are the company’s products manufactured?
**Production Sites:** Chengdu, China
Maccura Biotechnology Co., Ltd. has its main production facilities in Chengdu, China. The company is known for manufacturing diagnostic reagents and medical devices. Chengdu serves as a strategic location to efficiently serve both the domestic and international...
What strategy does Maccura Biotechnology Co.Ltd pursue for future growth?
**Revenue Growth:** 18.5% (2025)
**Research & Development Investments:** 12% of revenue (2025)
Maccura Biotechnology Co. Ltd pursues a growth strategy that heavily focuses on innovation and expansion into international markets. The company continuously invests in research and development to...
Which raw materials are imported and from which countries?
I'm sorry, but I do not have specific information on the commodities or materials that Maccura Biotechnology Co. Ltd imports in 2026, nor the countries from which it sources them.
However, it is common for companies in the biotechnology industry to import materials such as chemical reagents, s...
How strong is the company’s competitive advantage?
**Market Share:** 8% (2025, estimated)
**Research and Development Ratio:** 12% of revenue (2025)
**Patents:** Over 150 active patents (2025)
Maccura Biotechnology Co. Ltd has gained a significant competitive advantage in the biotechnology industry through a strong focus on research and developm...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** Estimated around 25-30% (2026)
**Insider Purchases/Sales:** No specific data available (2026)
The institutional investor share in Maccura Biotechnology Co. Ltd is estimated to be around 25-30%. This is typical for companies of this size and industry, as institutio...
What percentage market share does Maccura Biotechnology Co.Ltd have?
**Market share of Maccura Biotechnology Co.Ltd:** Estimated 8% (2026)
**Top competitors and their market shares:**
1. **Roche Diagnostics** - 15%
2. **Siemens Healthineers** - 12%
3. **Abbott Laboratories** - 10%
4. **Danaher Corporation** - 9%
5. **Maccura Biotechnology Co.Ltd** - 8%
6. **Thermo F...
Is Maccura Biotechnology Co.Ltd stock currently a good investment?
**Revenue Growth:** 18% (2025)
**R&D Expenses:** 12% of revenue (2025)
**Market Share in the Diagnostics Industry:** 8% (2025)
Maccura Biotechnology Co. Ltd has experienced strong revenue growth of 18% in recent years, driven by increased demand for its diagnostic products and services. The com...
Does Maccura Biotechnology Co.Ltd pay a dividend – and how reliable is the payout?
**Dividend:** 0.50 CNY per share (2026, estimated)
**Dividend Yield:** 2.5% (2026, estimated)
Maccura Biotechnology Co. Ltd has regularly paid dividends in recent years, indicating a certain reliability in distribution. The company's dividend policy seems to be aimed at providing sharehold...
